Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

Alessio Bruni, Vieri Scotti, Paolo Borghetti, Stefano Vagge, Salvatore Cozzi, Elisa D’Angelo, Niccolò Giaj Levra, Alessandra Fozza, Maria Taraborrelli, Gaia Piperno, Valentina Vanoni, Matteo Sepulcri, Marco Trovò, Valerio Nardone, Elisabetta Lattanzi, Said Bou Selman, Federica Bertolini, Davide Franceschini, Francesco Agustoni, Barbara Alicja Jereczek-Fossa, Stefano Maria Magrini, Lorenzo Livi, Frank Lohr, Andrea Riccardo Filippi

Open source

DOI: 10.3389/fonc.2021.802949
Published: 2021-11-16
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2021.802949,
  title = {Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer},
  author = {Alessio Bruni and Vieri Scotti and Paolo Borghetti and Stefano Vagge and Salvatore Cozzi and Elisa D’Angelo and Niccolò Giaj Levra and Alessandra Fozza and Maria Taraborrelli and Gaia Piperno and Valentina Vanoni and Matteo Sepulcri and Marco Trovò and Valerio Nardone and Elisabetta Lattanzi and Said Bou Selman and Federica Bertolini and Davide Franceschini and Francesco Agustoni and Barbara Alicja Jereczek-Fossa and Stefano Maria Magrini and Lorenzo Livi and Frank Lohr and Andrea Riccardo Filippi},
  year = {2021},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2021.802949},
  url = {https://doi.org/10.3389/fonc.2021.802949}
}

RIS

TY  - JOUR
TI  - Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
AU  - Alessio Bruni
AU  - Vieri Scotti
AU  - Paolo Borghetti
AU  - Stefano Vagge
AU  - Salvatore Cozzi
AU  - Elisa D’Angelo
AU  - Niccolò Giaj Levra
AU  - Alessandra Fozza
AU  - Maria Taraborrelli
AU  - Gaia Piperno
AU  - Valentina Vanoni
AU  - Matteo Sepulcri
AU  - Marco Trovò
AU  - Valerio Nardone
AU  - Elisabetta Lattanzi
AU  - Said Bou Selman
AU  - Federica Bertolini
AU  - Davide Franceschini
AU  - Francesco Agustoni
AU  - Barbara Alicja Jereczek-Fossa
AU  - Stefano Maria Magrini
AU  - Lorenzo Livi
AU  - Frank Lohr
AU  - Andrea Riccardo Filippi
PY  - 2021
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2021.802949
UR  - https://doi.org/10.3389/fonc.2021.802949
ER  -

APA

Bruni, A., Scotti, V., Borghetti, P., Vagge, S., Cozzi, S., D’Angelo, E., Levra, N. G., Fozza, A., Taraborrelli, M., Piperno, G., Vanoni, V., Sepulcri, M., Trovò, M., Nardone, V., Lattanzi, E., Selman, S. B., Bertolini, F., Franceschini, D., Agustoni, F., Jereczek-Fossa, B. A., Magrini, S. M., Livi, L., Lohr, F., & Filippi, A. R. (2021). Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2021.802949

Source records

crossref · retrieved 2026-09-26T20:04:20.256Z